Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

This publication has 43 references indexed in Scilit:

• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
  Published by Elsevier ,2007
• Candesartan- and Atenolol-Based Treatments Induce Different Patterns of Carotid Artery and Left Ventricular Remodeling in Hypertension
  Stroke, 2006
• Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen)
  Diabetes & Metabolism, 2005
• The Renin-Angiotensin System and the Developing Retinal Vasculature
  Investigative Opthalmology & Visual Science, 2005
• The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
  Journal of the Renin-Angiotensin-Aldosterone System, 2005
• The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design
  Journal of the Renin-Angiotensin-Aldosterone System, 2002
• Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures
  Hypertension, 2001
• UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
  Diabetologia, 2001
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• A Hybrid Algorithm for Computation of the Nonparametric Maximum Likelihood Estimator from Censored Data
  Journal of the American Statistical Association, 1997